Skip to content
healthcare.dev

Paliperidone

NDC 69367-434, Paliperidone, tablet, extended release, from Westminster Pharmaceuticals, LLC.

Product NDC
69367-434
Status
Listed
Labeler
Westminster Pharmaceuticals, LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218755
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69367-434 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PALIPERIDONE6 mg/1

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
69367-434-306936704343030 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-434-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1745a460-5e3a-4a1f-8eb3-64bb112f47a4
  • NADAC price for package 69367043430

    GET /v1/drugs/nadac/69367043430

Use it

Look up 69367-434 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69367-434 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69367-434. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.